Notably, ACSL4-deficient MM cells exhibit resistance to RSL3, while ACSL4-high cells are highly sensitive, supporting the rationale for targeting ferroptosis in ACSL4-overexpressing MM subtypes to overcome chemoresistance. The gene discussed is ACSL4; the disease is Miyoshi myopathy.